José Luis García-Giménez (1979, Spain), PhD. Bachelor in Chemistry and in Biochemistry (University of Valencia, UV). PhD in Chemistry (UV). Assistant Professor in the Department of Physiology in the Medicine and Dentistry School in the UV. Dr. García is Group Leader of the research group “Translational Epigenetics and Epigenomics” in the Biomedical Research Institute INCLIVA.

Over 17 years of continuous research in 37 funded projects (12 as PI) in national and international projects. He is author of more than 102 publications and 7 chapters in the field of rare diseases, epigenetics, biomarkers, and oxidative stress. He is inventor of 4 technologies related with epigenetic biomarkers, protected with 4 different international patent families, and co-founder of EpiDisease S.L. (Spin-Off from the Spanish Institute of Health ISCIII), which is developing epigenetic-based IVD solutions.

Dr. García has received 10 scientific and entrepreneurship national and international awards, including the National Award for Young Entrepreneurs in 2013 (awarded by the Spanish Ministry of Health) and the Leopold’s Flohe Award from the International Free Radical Research Society, the First Prize in The 2nd China (Jinan) New Growth Drivers International Innovation and Entrepreneurship Contest in 2019 and The First prize in The 2nd Eureka International Innovation and Entrepreneurship Competition in Melbourne (Australia).